1ncw:H     (ARG1) to   (VAL111)  CATIONIC CYCLIZATION ANTIBODY 4C6 IN COMPLEX WITH BENZOIC ACID  |   IMMUNOGLOBULIN, CATALYTIC ANTIBODY, CATIONIC CYCLIZATION REACTION, IMMUNE SYSTEM 
1nd0:B     (ARG1) to   (SER112)  CATIONIC CYCLIZATION ANTIBODY 4C6 COMPLEX WITH TRANSITION STATE ANALOG  |   IMMUNOGLOBULIN, CATALYTIC ANTIBODY, CATIONIC CYCLIZATION REACTION, IMMUNE SYSTEM 
1nd0:D     (ARG1) to   (SER112)  CATIONIC CYCLIZATION ANTIBODY 4C6 COMPLEX WITH TRANSITION STATE ANALOG  |   IMMUNOGLOBULIN, CATALYTIC ANTIBODY, CATIONIC CYCLIZATION REACTION, IMMUNE SYSTEM 
1nd0:F     (ARG1) to   (VAL111)  CATIONIC CYCLIZATION ANTIBODY 4C6 COMPLEX WITH TRANSITION STATE ANALOG  |   IMMUNOGLOBULIN, CATALYTIC ANTIBODY, CATIONIC CYCLIZATION REACTION, IMMUNE SYSTEM 
1nd0:H     (ARG1) to   (SER112)  CATIONIC CYCLIZATION ANTIBODY 4C6 COMPLEX WITH TRANSITION STATE ANALOG  |   IMMUNOGLOBULIN, CATALYTIC ANTIBODY, CATIONIC CYCLIZATION REACTION, IMMUNE SYSTEM 
1ndm:B   (GLU301) to   (SER412)  CRYSTAL STRUCTURE OF FAB FRAGMENT OF ANTIBODY HYHEL-26 COMPLEXED WITH LYSOZYME  |   ANTIBODY; LYSOZYME; MUTANT; HYHEL-26, IMMUNE SYSTEM/HYDROLASE COMPLEX 
1nj9:H     (VAL2) to   (SER112)  COCAINE HYDROLYTIC ANTIBODY 15A10  |   IMMUNOGLOBULIN, IMMUNE SYSTEM 
2axh:B     (GLY5) to   (VAL113)  CRYSTAL STRUCTURES OF T CELL RECEPTOR BETA CHAINS RELATED TO RHEUMATOID ARTHRITIS  |   TCR, IMMUNE SYSTEM 
2axj:A     (GLY5) to   (VAL113)  CRYSTAL STRUCTURES OF T CELL RECEPTOR BETA CHAINS RELATED TO RHEUMATOID ARTHRITIS  |   TCR, IMMUNE SYSTEM 
2axj:B     (GLY5) to   (VAL113)  CRYSTAL STRUCTURES OF T CELL RECEPTOR BETA CHAINS RELATED TO RHEUMATOID ARTHRITIS  |   TCR, IMMUNE SYSTEM 
1aif:H     (VAL2) to   (VAL119)  ANTI-IDIOTYPIC FAB 409.5.3 (IGG2A) FAB FROM MOUSE  |   IMMUNOGLOBULIN, C REGION, V REGION 
1aif:B     (VAL2) to   (VAL119)  ANTI-IDIOTYPIC FAB 409.5.3 (IGG2A) FAB FROM MOUSE  |   IMMUNOGLOBULIN, C REGION, V REGION 
4x0k:H     (GLN3) to   (SER112)  ENGINEERED FAB FRAGMENT SPECIFIC FOR EYMPME (EE) PEPTIDE  |   ANTIBODY FRAGMENT, CRYSTALLIZATION CHAPERONE, FAB FRAGMENT, IMMUNE SYSTEM 
4x0k:A     (VAL2) to   (SER112)  ENGINEERED FAB FRAGMENT SPECIFIC FOR EYMPME (EE) PEPTIDE  |   ANTIBODY FRAGMENT, CRYSTALLIZATION CHAPERONE, FAB FRAGMENT, IMMUNE SYSTEM 
3eyf:B     (VAL2) to   (SER124)  CRYSTAL STRUCTURE OF ANTI-HUMAN CYTOMEGALOVIRUS ANTIBODY 8F9 PLUS GB PEPTIDE  |   CYTOMEGALOVIRUS, ANTIBODY, IMMUNOGLOBULIN DOMAIN, CLEAVAGE ON PAIR OF BASIC RESIDUES, ENVELOPE PROTEIN, GLYCOPROTEIN, HOST-VIRUS INTERACTION, MEMBRANE, TRANSMEMBRANE, VIRION, IMMUNE SYSTEM 
2pcp:D     (GLU1) to   (SER112)  ANTIBODY FAB COMPLEXED WITH PHENCYCLIDINE  |   IMMUNOGLOBULIN 
4x6d:H     (GLY3) to   (GLU116)  CD1A TERNARY COMPLEX WITH ENDOGENOUS LIPIDS AND BK6 TCR  |   CD1A, TCR, IMMUNE COMPLEX, LIPID ANTIGEN, IMMUNE SYSTEM 
4x7s:H     (GLN3) to   (VAL119)  STRUCTURE OF OMALIZUMAB FAB FRAGMENT CRYSTAL FORM 1  |   ANTIBODY FAB FRAGMENT, ANTI-IGE ANTIBODY, ANTI-INFLAMMATORY, IMMUNE SYSTEM 
1oax:L     (ALA2) to   (LEU109)  FV STRUCTURE OF THE IGE SPE-7 IN COMPLEX WITH ACENAPHTHENEQUINONE  |   IMMUNE SYSTEM, ANTIBODY-COMPLEX, ANTIBODY, ALLERGY, IGE 
1oax:N     (ALA2) to   (LEU109)  FV STRUCTURE OF THE IGE SPE-7 IN COMPLEX WITH ACENAPHTHENEQUINONE  |   IMMUNE SYSTEM, ANTIBODY-COMPLEX, ANTIBODY, ALLERGY, IGE 
1ocw:L     (ALA2) to   (LEU109)  FREE CONFORMATION AB2 OF THE IGE SPE-7  |   ANTIBODY, ALLERGY, CONFORMATIONAL DIVERSITY, IMMUNE SYSTEM, MULTISPECIFICITY 
3sbw:B    (SER34) to   (THR145)  CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN THE EXTRACELLULAR DOMAINS OF MOUSE PD-1 MUTANT AND HUMAN PD-L1  |   PD-1; PD-L1; B7-H1; PROGRAMMED DEATH-1 LIGAND 1, COMPLEX, COSTIMULATORY, IMMUNE SYSTEM 
2bx5:C     (GLN3) to   (ILE106)  IS FR1 THE ANTIBODY'S ACHILLIES HEEL  |   IMMUNE SYSTEM, AMYLOID, LCDD, ANTIBODY, AGGREGATION, FR1 
4xi5:D     (GLU1) to   (VAL119)  GHGL OF VARICELLA-ZOSTER VIRUS IN COMPLEX WITH HUMAN NEUTRALIZING ANTIBODIES  |   COMPLEX, NEUTRALIZATION EPITOPE, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX 
3skj:H     (VAL2) to   (SER112)  STRUCTURAL AND FUNCTIONAL CHARACTERIZATION OF AN AGONISTIC ANTI-HUMAN EPHA2 MONOCLONAL ANTIBODY  |   FAB, RECEPTOR, IG FOLD, EPHRIN RECEPTOR, ANTIBODY, ANTIGEN, EXTRA- CELLULAR, IMMUNE SYSTEM 
4iiq:B     (VAL4) to   (GLU116)  CRYSTAL STRUCTURE OF A HUMAN MAIT TCR IN COMPLEX WITH BOVINE MR1  |   MHC-CLASS I, IMMUNOGLOBULIN DOMAIN, IMMUNE SYSTEM, ANTIGEN PRESENTATION, ANTIGEN RECOGNITION, CELL MEMBRANE 
1dqj:B     (GLU1) to   (VAL111)  CRYSTAL STRUCTURE OF THE ANTI-LYSOZYME ANTIBODY HYHEL-63 COMPLEXED WITH HEN EGG WHITE LYSOZYME  |   ANTIBODY, PROTEIN-PROTEIN COMPLEX, HEN EGG WHITE LYSOZYME, IMMUNE SYSTEM/HYDROLASE COMPLEX 
1dqq:B     (GLU1) to   (SER112)  CRYSTAL STRUCTURE OF ANTI-LYSOZYME ANTIBODY HYHEL-63  |   ANTI-LYSOZYME ANTIBODY, HYHEL-63, HEN EGG WHITE LYSOZYME, IMMUNE SYSTEM 
2dqc:H     (ASP1) to   (SER112)  CRYSTAL STRUCTURE OF HYHEL-10 FV MUTANT(HY33F) COMPLEXED WITH HEN EGG LYSOZYME  |   ANTIGEN-ANTIBODY COMPLEX, MUTANT, IMMUNE SYSTEM/HYDROLASE COMPLEX 
4yhp:F     (VAL3) to   (THR110)  CRYSTAL STRUCTURE OF 309M3-B FAB IN COMPLEX WITH H3K9ME3 PEPTIDE  |   ANTIBODY, FAB, HEAD-TO-HEAD DIMERIZATION, H3K9ME3, IMMUNE SYSTEM 
3tzv:B     (ASP3) to   (GLU118)  CRYSTAL STRUCTURE OF AN INKT TCR IN COMPLEX WITH CD1D- LYSOPHOSPHATIDYLCHOLINE  |   IMMUNOGLOBULIN-LIKE, MHC CLASS I-LIKE, ANTIGEN RECOGNITION, CD1D, CELL SURFACE, IMMUNE SYSTEM 
3tzv:H     (ASP3) to   (GLU118)  CRYSTAL STRUCTURE OF AN INKT TCR IN COMPLEX WITH CD1D- LYSOPHOSPHATIDYLCHOLINE  |   IMMUNOGLOBULIN-LIKE, MHC CLASS I-LIKE, ANTIGEN RECOGNITION, CD1D, CELL SURFACE, IMMUNE SYSTEM 
1f4x:L     (GLN1) to   (LEU109)  CRYSTAL STRUCTURE OF AN ANTI-CARBOHYDRATE ANTIBODY DIRECTED AGAINST VIBRIO CHOLERAE O1 IN COMPLEX WITH ANTIGEN  |   ANTI-CARBOHYDRATE ANTIBODY, IMMUNE SYSTEM 
1ruk:H     (ARG1) to   (SER112)  CRYSTAL STRUCTURE (C) OF NATIVE CATIONIC CYCLIZATION ANTIBODY 4C6 FAB AT PH 4.6 WITH A DATA SET COLLECTED AT SSRL BEAMLINE 9-1  |   IMMUNOGLOBULIN, CATALYTIC ANTIBODY, WATER OXIDATION, AMINO ACID MODIFICATION, IMMUNE SYSTEM 
1rum:H     (VAL2) to   (SER112)  CRYSTAL STRUCTURE (F) OF H2O2-SOAKED CATIONIC CYCLIZATION ANTIBODY 4C6 FAB AT PH 8.5 WITH A DATA SET COLLECTED AT SSRL BEAMLINE 9-1.  |   IMMUNOGLOBULIN, CATALYTIC ANTIBODY, WATER OXIDATION, AMINO ACID MODIFICATION, IMMUNE SYSTEM 
4zez:J     (ASP3) to   (GLU112)  CRYSTAL STRUCTURE OF HCV 1406 TCR/HCV NS3: 1406-1415/HLA-A2 COMPLEX  |   HCV TCR, HLA-A2, HCV NS3:1406-1415 PEPTIDE, DECAPEPTIDE, PROTEIN BINDING, IMMUNE SYSTEM COMPLEX, PROTEIN BINDING-IMMUNE SYSTEM COMPLEX 
4zez:H     (ASP3) to   (GLU112)  CRYSTAL STRUCTURE OF HCV 1406 TCR/HCV NS3: 1406-1415/HLA-A2 COMPLEX  |   HCV TCR, HLA-A2, HCV NS3:1406-1415 PEPTIDE, DECAPEPTIDE, PROTEIN BINDING, IMMUNE SYSTEM COMPLEX, PROTEIN BINDING-IMMUNE SYSTEM COMPLEX 
2vlm:E     (GLY5) to   (GLU115)  THE STRUCTURAL DYNAMICS AND ENERGETICS OF AN IMMUNODOMINANT T-CELL RECEPTOR ARE PROGRAMMED BY ITS VBETA DOMAIN  |   IMMUNE SYSTEM, HOST-VIRUS INTERACTION, IMMUNE SYSTEM/RECEPTOR/COMPLEX, IMMUNODOMINANCE, IMMUNOGLOBULIN DOMAIN, TCR, MHC, FLU, MHC I, T-CELL, COMPLEX, MEMBRANE, RECEPTOR, IMMUNE RESPONSE 
2vxu:I     (ILE2) to   (SER112)  CRYSTAL STRUCTURE OF MURINE REFERENCE ANTIBODY 125-2H FAB FRAGMENT  |   FAB, IL-18, AUTOIMMUNITY, TH1/TH2 CELLS, IMMUNE SYSTEM 
2gk0:B     (VAL2) to   (SER112)  STRUCTURE OF CATALYTIC ELIMINATION ANTIBODY 13G5 FROM A TWINNED CRYSTAL IN SPACE GROUP C2  |   IMMUNOGLOBULIN,CATALYTIC ANTIBODY, ELIMINATION, IMMUNE SYSTEM 
3iet:B     (VAL2) to   (VAL111)  CRYSTAL STRUCTURE OF 237MAB WITH ANTIGEN  |   GLYCOPEPITDE, ANTIBODY, FAB, CARBOHYDRATE-BIDING, TUMOUR, IMMUNE SYSTEM 
3if1:B     (VAL2) to   (VAL111)  CRYSTAL STRUCTURE OF 237MAB IN COMPLEX WITH A GALNAC  |   GLYCOPEPITDE, ANTIBODY, FAB, CARBOHYDRATE-BIDING, TUMOUR, IMMUNE SYSTEM 
4zs6:H     (VAL2) to   (SER120)  RECEPTOR BINDING DOMAIN AND FAB COMPLEX  |   COMPLEX, FAB, RECEPTOR BINDING DOMAIN, IMMUNE SYSTEM 
4zs6:C     (VAL2) to   (SER120)  RECEPTOR BINDING DOMAIN AND FAB COMPLEX  |   COMPLEX, FAB, RECEPTOR BINDING DOMAIN, IMMUNE SYSTEM 
3iy5:B   (VAL110) to   (VAL227)  VARIABLE DOMAINS OF THE MOUSE FAB (1AIF) FITTED INTO THE CRYOEM RECONSTRUCTION OF THE VIRUS-FAB 16 COMPLEX  |   CRYOEM, NEUTRALIZING ANTIBODY, PARVOVIRUS, CANINE, FELINE, FAB FOOTPRINT, IMMUNE SYSTEM 
3vrl:E     (VAL2) to   (SER121)  CRYSTAL STRUCTURE OF BMJ4 P24 CAPSID PROTEIN IN COMPLEX WITH A10F9 FAB  |   HIV-1 CAPSIDE P24, CAPSID PROTEIN, IMMUNE SYSTEM-VIRAL PROTEIN COMPLEX 
1tzi:B     (GLN3) to   (VAL111)  CRYSTAL STRUCTURE OF THE FAB YADS2 COMPLEXED WITH H-VEGF  |   PHAGE DISPLAY, ANTIBODY LIBRARY, PROTEIN ENGINEERING, IMMUNE SYSTEM 
4lri:C     (GLU2) to   (SER129)  ANTI CMV FAB FRAGMENT  |   FAB FRAGMENT, CMV NEUTRALIZING ANTIBODY, GLYCOPROTEIN H OR GH FROM CMV, IMMUNE SYSTEM 
1u3h:B     (ALA3) to   (LEU117)  CRYSTAL STRUCTURE OF MOUSE TCR 172.10 COMPLEXED WITH MHC CLASS II I-AU MOLECULE AT 2.4 A  |   COMPLEX, IMMUNE SYSTEM 
1uac:H     (VAL2) to   (SER112)  CRYSTAL STRUCTURE OF HYHEL-10 FV MUTANT SFSF COMPLEXED WITH TURKEY WHITE LYSOZYME  |   ANTIGEN-ANTIBODY COMPLEX, HYHEL-10, MUTANT, ANTI-LYSOZYME ANTIBODY, IMMUNE SYSTEM/HYDROLASE COMPLEX 
2wzp:L     (GLN3) to   (SER123)  STRUCTURES OF LACTOCOCCAL PHAGE P2 BASEPLATE SHED LIGHT ON A NOVEL MECHANISM OF HOST ATTACHMENT AND ACTIVATION IN SIPHOVIRIDAE  |   BASEPLATE, VIRAL PROTEIN 
3wd5:H     (VAL2) to   (VAL119)  CRYSTAL STRUCTURE OF TNFALPHA IN COMPLEX WITH ADALIMUMAB FAB FRAGMENT  |   ANTIBODY BINDING EPITOPE, IMMUNE SYSTEM 
5ado:H     (VAL2) to   (SER118)  CRYSTAL STRUCTURE OF THE PARAOXON-MODIFIED A.17 ANTIBODY FAB FRAGMENT - LIGHT CHAIN S35R MUTANT  |   IMMUNE SYSTEM, ENZYME REPROGRAMMING, ANTIBODIES, IG SUPERFAMILY, IN SILICO ANTIBODY MATURATION 
5adp:H     (VAL2) to   (SER118)  CRYSTAL STRUCTURE OF THE A.17 ANTIBODY FAB FRAGMENT - LIGHT CHAIN S35R MUTANT  |   IMMUNE SYSTEM, ENZYME REPROGRAMMING, ANTIBODIES, IG SUPERFAMILY, IN SILICO ANTIBODY MATURATION 
1jnh:A     (ALA2) to   (VAL108)  CRYSTAL STRUCTURE OF FAB-ESTRADIOL COMPLEXES  |   IGG FOLD, ANTIBODY-HAPTEN COMPLEX, ESTRADIOL, IMMUNE SYSTEM 
2xna:B     (GLY5) to   (GLU115)  CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN HUMAN T CELL RECEPTOR AND STAPHYLOCOCCAL ENTEROTOXIN  |   IMMUNE SYSTEM, SUPERANTIGEN 
1w72:H     (VAL2) to   (VAL111)  CRYSTAL STRUCTURE OF HLA-A1:MAGE-A1 IN COMPLEX WITH FAB- HYB3  |   IMMUNE SYSTEM, HLA/FAB FRAGMENT, HUMAN LEUCOCYTE ANTIGEN, PEPTIDE-SPECIFIC FAB, TCR-LIKE BINDING, MHC-I 
3zhl:A     (VAL2) to   (VAL117)  THE CRYSTAL STRUCTURE OF SINGLE DOMAIN ANTIBODY 8-14 SCAFFOLD  |   IMMUNE SYSTEM, SINGLE DOMAIN ANTIBODY 
2xza:H     (VAL2) to   (SER118)  CRYSTAL STRUCTURE OF RECOMBINANT A.17 ANTIBODY FAB FRAGMENT  |   IMMUNE SYSTEM 
2xzc:H     (VAL2) to   (SER118)  CRYSTAL STRUCTURE OF PHOSPHONATE-MODIFIED RECOMBINANT A.17 ANTIBODY FAB FRAGMENT  |   IMMUNE SYSTEM 
4nkd:A     (VAL2) to   (SER121)  CRYSTAL STRUCTURE OF ENGINEERED ANTI-EE SCFV ANTIBODY FRAGMENT  |   ANTIBODY FRAGMENT, EYMPME BINDING, IMMUNE SYSTEM, IMMUNE SYSTEM- CHAPERONE COMPLEX 
4nkd:C     (VAL2) to   (SER121)  CRYSTAL STRUCTURE OF ENGINEERED ANTI-EE SCFV ANTIBODY FRAGMENT  |   ANTIBODY FRAGMENT, EYMPME BINDING, IMMUNE SYSTEM, IMMUNE SYSTEM- CHAPERONE COMPLEX 
4nkd:E     (GLN3) to   (SER121)  CRYSTAL STRUCTURE OF ENGINEERED ANTI-EE SCFV ANTIBODY FRAGMENT  |   ANTIBODY FRAGMENT, EYMPME BINDING, IMMUNE SYSTEM, IMMUNE SYSTEM- CHAPERONE COMPLEX 
4nkd:G     (GLN3) to   (SER121)  CRYSTAL STRUCTURE OF ENGINEERED ANTI-EE SCFV ANTIBODY FRAGMENT  |   ANTIBODY FRAGMENT, EYMPME BINDING, IMMUNE SYSTEM, IMMUNE SYSTEM- CHAPERONE COMPLEX 
4nqc:H     (GLY3) to   (GLU116)  CRYSTAL STRUCTURE OF TCR-MR1 TERNARY COMPLEX AND COVALENTLY BOUND 5- (2-OXOPROPYLIDENEAMINO)-6-D-RIBITYLAMINOURACIL  |   MR1, T-CELL RECEPTOR, IMMUNE RECEPTOR COMPLEX, IG-FOLD, PROTEIN BINDING, SCHIFF BASE, MEMBRANE, IMMUNE SYSTEM 
1kn2:H     (MET2) to   (SER112)  CATALYTIC ANTIBODY D2.3 COMPLEX  |   ABZYME, TRANSITION STATE ANALOG, IMMUNE SYSTEM 
1kn4:H     (MET2) to   (SER112)  CATALYTIC ANTIBODY D2.3 COMPLEX  |   ABZYME, TRANSITION STATE ANALOG, IMMUNE SYSTEM 
1xct:C     (VAL3) to   (ALA115)  COMPLEX HCV CORE-FAB 19D9D6-PROTEIN L MUTANT (D55A, L57H, Y64W) IN SPACE GROUP P21212  |   CRYSTAL PACKING, FAB, PROTEIN L, PEPTIDE COMPLEX, IMMUNE SYSTEM 
4nzr:H     (GLN1) to   (SER112)  CRYSTAL STRUCTURE OF THE ANTIBODY-BINDING REGION OF PROTEIN M (PROTEIN M TD) IN COMPLEX WITH ANTI-HIV ANTIBODY PGT135 FAB  |   LEUCINE-RICH REPEAT, BROAD ANTIBODY-BINDING, BLOCK ANTIBODY-ANTIGEN UNION, VARIABLE REGION, IMMUNE SYSTEM-PROTEIN BINDING COMPLEX 
2ntf:A     (ALA2) to   (VAL106)  CRYSTAL STRUCTURE OF A QUORUM-QUENCHING ANTIBODY IN COMPLEX WITH AN N- ACYL-L-HOMOSERINE LACTONE ANALOG  |   IMMUNOGLOBULIN, ANTIBODY, FAB, HAPTEN COMPLEX, QUORUM SENSING, HOMOSERINE LACTONE, IMMUNE SYSTEM 
1xgr:B     (ALA1) to   (VAL111)  STRUCTURE FOR ANTIBODY HYHEL-63 Y33I MUTANT COMPLEXED WITH HEN EGG LYSOZYME  |   HYHEL-63, 2.1A CRYSTAL STRUCTURE, Y33I MUTANT, IMMUNE SYSTEM 
1xgu:B     (GLU1) to   (VAL111)  STRUCTURE FOR ANTIBODY HYHEL-63 Y33F MUTANT COMPLEXED WITH HEN EGG LYSOZYME  |   HYHEL-63, 2.1A CRYSTAL STRUCTURE, Y33F MUTANT, IMMUNE SYSTEM 
2ypl:E     (GLY3) to   (GLU111)  STRUCTURAL FEATURES UNDERLYING T-CELL RECEPTOR SENSITIVITY TO CONCEALED MHC CLASS I MICROPOLYMORPHISMS  |   IMMUNE SYSTEM-VIRAL PROTEIN COMPLEX, MICROPOLYMORPHISM 
4odu:H     (VAL2) to   (VAL111)  UNLIGANDED FAB STRUCTURE OF LIPID A-SPECIFIC ANTIBODY S1-15  |   CARBOHYDRATE BINDING, IMMUNE SYSTEM 
4onf:H     (VAL2) to   (SER118)  FAB FRAGMENT OF 3D6 IN COMPLEX WITH AMYLOID BETA 1-7  |   ANTIBODY, AMYLOID BETA PEPTIDE, IMMUNE SYSTEM 
4ong:H     (VAL2) to   (VAL117)  FAB FRAGMENT OF 3D6 IN COMPLEX WITH AMYLOID BETA 1-40  |   ANTIBODY, AMYLOID BETA PEPTIDE, IMMUNE SYSTEM 
1mhp:H     (GLN3) to   (SER117)  CRYSTAL STRUCTURE OF A CHIMERIC ALPHA1 INTEGRIN I-DOMAIN IN COMPLEX WITH THE FAB FRAGMENT OF A HUMANIZED NEUTRALIZING ANTIBODY  |   INTEGRIN, CELL ADHESION, RECEPTOR, ANTIBODY, IMMUNE SYSTEM 
5d1z:G     (VAL3) to   (SER121)  ISDB NEAT1 BOUND BY CLONE D4-10  |   ISDB, NEAT1, GERMLINE ENCODED, IMMUNE SYSTEM 
4p5t:A     (GLN2) to   (GLN115)  14.C6 TCR COMPLEXED WITH MHC CLASS II I-AB/3K PEPTIDE  |   MHC, TCR, IMMUNE RECEPTOR, IG-LIKE DOMAIN, IMMUNE SYSTEM 
5d7s:H     (VAL2) to   (SER116)  CRYSTAL STRUCTURE OF MOR04357, A NEUTRALIZING ANTI-HUMAN GM-CSF ANTIBODY FAB FRAGMENT  |   GM-CSF, AFFINITY MATURATION, PHAGE DISPLAY, CYTOKINE, ANTIBODY, PROTEROS BIOSTRUCTURES GMBH, IMMUNE SYSTEM 
1yec:H     (MET2) to   (SER112)  STRUCTURE OF A CATALYTIC ANTIBODY IGG2A FAB FRAGMENT (D2.3)  |   CATALYTIC ANTIBODY, TRANSITION STATE ANALOGUE 
1yee:H     (VAL2) to   (SER112)  STRUCTURE OF A CATALYTIC ANTIBODY, IGG2A FAB FRAGMENT (D2.5)  |   CATALYTIC ANTIBODY, TRANSITION STATE ANALOGUE 
1yeg:H     (MET2) to   (SER112)  STRUCTURE OF IGG2A FAB FRAGMENT (D2.3) COMPLEXED WITH REACTION PRODUCT  |   CATALYTIC ANTIBODY 
1yej:H     (MET2) to   (SER112)  CATALYTIC ANTIBODY COMPLEX  |   ABZYME, TRANSITION STATE ANALOG, IMMUNE SYSTEM 
1yek:H     (MET2) to   (SER112)  CATALYTIC ANTIBODY D2.3 COMPLEX  |   ABZYME, REACTION PRODUCT, IMMUNE SYSTEM 
4pjb:F     (GLY3) to   (GLU115)  STRUCTURE OF HUMAN MR1-5-OP-RU IN COMPLEX WITH HUMAN MAIT B-F3-C1 TCR  |   MR1, TCR, IMMUNE COMPLEX, 5-OP-RU, IMMUNE SYSTEM 
4pjf:F     (GLY3) to   (GLU115)  STRUCTURE OF HUMAN MR1-AC-6-FP IN COMPLEX WITH HUMAN MAIT B-C10 TCR  |   MR1, TCR, IMMUNE COMPLEX, AC-6-FP, IMMUNE SYSTEM 
4pji:H     (GLY3) to   (GLU114)  STRUCTURE OF HUMAN MR1-AC-6-FP IN COMPLEX WITH HUMAN MAIT C-C10 TCR  |   MR1, TCR, IMMUNE COMPLEX, AC-6-FP, IMMUNE SYSTEM 
3ldb:C     (GLN1) to   (SER117)  STRUCTURE OF JMJD6 COMPLEXD WITH ALPHA-KETOGLUTARATE AND FAB FRAGMENT.  |   JMJ6D, ALPHA-KETOGLUTARATE, FAB FRAGMENTS, IMMUNE SYSTEM 
5e2t:H     (GLN3) to   (VAL111)  CRYSTAL STRUCTURE OF ANTI-TAU ANTIBODY AT8 FAB  |   IMMUNE SYSTEM 
5e2v:H     (VAL2) to   (VAL111)  ANTI-TAU AT8 FAB WITH DOUBLY PHOSPHORYLATED TAU PEPTIDE  |   IMMUNE SYSTEM 
5e9d:E     (GLY3) to   (GLU116)  RD-1 MART-1 HIGH BOUND TO MART-1 DECAMERIC PEPTIDE (ELA) IN COMPLEX WITH HLA-A2  |   SINGLE CHAIN TCR-PMHC COMPLEX, PROTEIN BINDING 
5e9d:J     (GLY3) to   (THR115)  RD-1 MART-1 HIGH BOUND TO MART-1 DECAMERIC PEPTIDE (ELA) IN COMPLEX WITH HLA-A2  |   SINGLE CHAIN TCR-PMHC COMPLEX, PROTEIN BINDING 
3b2u:C     (VAL2) to   (SER120)  CRYSTAL STRUCTURE OF ISOLATED DOMAIN III OF THE EXTRACELLULAR REGION OF THE EPIDERMAL GROWTH FACTOR RECEPTOR IN COMPLEX WITH THE FAB FRAGMENT OF IMC-11F8  |   CELL SURFACE RECEPTOR; GLYCOPROTEIN; ANTIGEN:ANTIBODY COMPLEX; FAB FRAGMENT; ANTITUMOR; DRUG, ANTI-ONCOGENE, ATP-BINDING, CELL CYCLE, DISEASE MUTATION, KINASE, MEMBRANE, NUCLEOTIDE-BINDING, PHOSPHOPROTEIN, SECRETED, TRANSFERASE, TRANSMEMBRANE, TYROSINE- PROTEIN KINASE, IMMUNE SYSTEM-TRANSFERASE COMPLEX 
2adj:B     (VAL2) to   (VAL111)  CRYSTAL STRUCTURE OF MONOCLONAL ANTI-CD4 ANTIBODY Q425 IN COMPLEX WITH CALCIUM  |   ANTI-CD4, INTERFACIAL METAL, ANTIBODY RECOGNITION, IMMUNE SYSTEM 
3b9k:B     (LEU1) to   (VAL117)  CRYSTAL STRUCTURE OF CD8ALPHA-BETA IN COMPLEX WITH YTS 156.7 FAB  |   IMMUNOGLOBULIN DOMAIN, V-SET, IGSF DIMER, GLYCOPROTEIN, IMMUNE RESPONSE, MEMBRANE, TRANSMEMBRANE, IMMUNE SYSTEM 
3b9k:F     (LEU1) to   (VAL117)  CRYSTAL STRUCTURE OF CD8ALPHA-BETA IN COMPLEX WITH YTS 156.7 FAB  |   IMMUNOGLOBULIN DOMAIN, V-SET, IGSF DIMER, GLYCOPROTEIN, IMMUNE RESPONSE, MEMBRANE, TRANSMEMBRANE, IMMUNE SYSTEM 
4qok:E     (THR3) to   (GLU115)  STRUCTURAL BASIS FOR INEFFECTIVE T-CELL RESPONSES TO MHC ANCHOR RESIDUE IMPROVED HETEROCLITIC PEPTIDES  |   IMMUNOGLOBULIN, HLA, TCR, MELANOMA, IMMUNE SYSTEM 
3bdx:B     (ASN1) to   (LEU111)  CRYSTAL STRUCTURE OF THE UNSTABLE AND HIGHLY FIBRILLOGENIC PRO7SER MUTANT OF THE RECOMBINANT VARIABLE DOMAIN 6AJL2  |   LAMBDA VI SUBGROUP, LIGHT CHAIN VARIABLE DOMAIN, BETA-SANDWICH, IMMUNOGLOBULIN, AL AMYLOIDOSIS, IMMUNE SYSTEM 
3bdx:C     (PHE2) to   (VAL110)  CRYSTAL STRUCTURE OF THE UNSTABLE AND HIGHLY FIBRILLOGENIC PRO7SER MUTANT OF THE RECOMBINANT VARIABLE DOMAIN 6AJL2  |   LAMBDA VI SUBGROUP, LIGHT CHAIN VARIABLE DOMAIN, BETA-SANDWICH, IMMUNOGLOBULIN, AL AMYLOIDOSIS, IMMUNE SYSTEM 
4qrp:J     (ASP2) to   (PRO125)  CRYSTAL STRUCTURE OF HLA B*0801 IN COMPLEX WITH HSKKKCDEL AND DD31 TCR  |   HLA B*0801, HUAMN HEPATITIS C VIRUS, TCR, T CELL, IMMUNE SYSTEM 
4qth:B     (ILE2) to   (ILE106)  CRYSTAL STRUCTURE OF ANTI-UPAR FAB 8B12  |   ANTIBODY, IMMUNE SYSTEM 
5euo:H     (GLY1) to   (GLU111)  PF6-M1-HLA-A2  |   TCR, FLU, MHC, IMMUNE SYSTEM 
3c5z:B     (ALA1) to   (GLU111)  CRYSTAL STRUCTURE OF MOUSE MHC CLASS II I-AB/3K PEPTIDE COMPLEXED WITH MOUSE TCR B3K506  |   TCR-PMHC COMPLEX, GLYCOPROTEIN, IMMUNE RESPONSE, MEMBRANE, MHC II, TRANSMEMBRANE, SUGAR BINDING PROTEIN-IMMUNE SYSTEM COMPLEX 
3c5z:F     (ALA1) to   (GLU111)  CRYSTAL STRUCTURE OF MOUSE MHC CLASS II I-AB/3K PEPTIDE COMPLEXED WITH MOUSE TCR B3K506  |   TCR-PMHC COMPLEX, GLYCOPROTEIN, IMMUNE RESPONSE, MEMBRANE, MHC II, TRANSMEMBRANE, SUGAR BINDING PROTEIN-IMMUNE SYSTEM COMPLEX 
4r90:H     (VAL2) to   (VAL120)  ANTI CD70 LLAMA GLAMA FAB 27B3  |   IMMUNOGLOBULIN FOLD, IMMUNE SYSTEM, HUMAN CD70 
4c56:H     (GLY5) to   (GLU115)  X-RAY STRUCTURE OF THE COMPLEX BETWEEN STAPHYLOCOCCAL ENTEROTOXIN B, T CELL RECEPTOR AND MAJOR HISTOCOMPATIBILITY COMPLEX CLASS II  |   IMMUNE SYSTEM-TOXIN COMPLEX 
3d3v:E     (VAL4) to   (GLU117)  THE COMPLEX BETWEEN TCR A6 AND HUMAN CLASS I MHC HLA-A2 WITH THE MODIFIED HTLV-1 TAX (Y5(3,4-DIFLUOROPHENYLALANINE)) PEPTIDE  |   HTLV-1 TAX PEPTIDE, 3, 4-DIFLUOROPHENYLALANINE, MHC CLASS I, HLA-A2, T-CELL RECEPTOR A6, GLYCOPROTEIN, HOST-VIRUS INTERACTION, IMMUNE RESPONSE, MEMBRANE, MHC I, PHOSPHOPROTEIN, TRANSMEMBRANE, IMMUNOGLOBULIN DOMAIN, SECRETED, DISEASE MUTATION, GLYCATION, PYRROLIDONE CARBOXYLIC ACID, IMMUNE SYSTEM 
4dkf:H     (GLN3) to   (VAL111)  CRYSTAL STRUCTURE OF HUMAN INTERLEUKIN-34 BOUND TO FAB2  |   DIMERIC FOUR-HELIX BUNDLE CYTOKINE, IGG, GLYCOSYLATION, CYTOKINE- IMMUNE SYSTEM COMPLEX 
5i1h:H     (VAL2) to   (SER117)  CRYSTAL STRUCTURE OF HUMAN GERMLINE ANTIBODY IGHV3-53/IGKV3-20  |   MONOCLONAL ANTIBODY, IMMUNE SYSTEM 
3qh3:B     (VAL4) to   (GLU116)  THE CRYSTAL STRUCTURE OF TCR A6  |   TAX PEPTIDE, TEL1P PEPTIDE, NONAPEPTIDE, MHC CLASS I, HLA-A2, TCR A6, CROSS-REACTIVITY, IMMUNE SYSTEM 
3qh3:D     (GLY3) to   (GLU116)  THE CRYSTAL STRUCTURE OF TCR A6  |   TAX PEPTIDE, TEL1P PEPTIDE, NONAPEPTIDE, MHC CLASS I, HLA-A2, TCR A6, CROSS-REACTIVITY, IMMUNE SYSTEM 
5j74:A     (VAL2) to   (VAL120)  FLUOROGEN ACTIVATING PROTEIN AM2.2 IN COMPLEX WITH TO1-2P  |   FLUOROGEN ACTIVATING PROTEIN DRUG DISCOVERY BIOSENSOR PROTEIN TRAFFICKING, PROTEIN BINDING, IMMUNE SYSTEM 
5j74:B     (VAL2) to   (VAL120)  FLUOROGEN ACTIVATING PROTEIN AM2.2 IN COMPLEX WITH TO1-2P  |   FLUOROGEN ACTIVATING PROTEIN DRUG DISCOVERY BIOSENSOR PROTEIN TRAFFICKING, PROTEIN BINDING, IMMUNE SYSTEM 
3qo0:B     (VAL2) to   (VAL117)  MONOCLINIC FORM OF IGG1 FAB FRAGMENT (IN COMPLEX WITH ANTIGENIC PEPTIDE) SHARING SAME FV AS IGA  |   IMMUNOGLOBULIN FOLD, IMMUNE SYSTEM 
3qo1:B     (VAL2) to   (VAL117)  MONOCLINIC FORM OF IGG1 FAB FRAGMENT (APO FORM) SHARING SAME FV AS IGA  |   IMMUNOGLOBULIN FOLD, ANTIBODY, SERUM, IMMUNE SYSTEM 
3qum:K     (VAL2) to   (SER112)  CRYSTAL STRUCTURE OF HUMAN PROSTATE SPECIFIC ANTIGEN (PSA) IN FAB SANDWICH WITH A HIGH AFFINITY AND A PCA SELECTIVE ANTIBODY  |   KALLIKREIN FOLD, PROSTATE-SPECIFIC ANTIGEN, SERINE PROTEASE, NEGATIVE REGULATION OF ANGIOGENESIS, NATURAL POST-TRANSDUCTIONAL MODIFICATION, N-LINKED AND O-LINKED GLYCOSYLATION, IMMUNE SYSTEM 
2ajx:H     (GLU1) to   (VAL111)  CRYSTAL STRUCTURE OF COCAINE CATALYTIC ANTIBODY 7A1 FAB' IN COMPLEX WITH TRANSITION STATE ANALOG  |   CATALYTIC ANTIBODY, FAB, TRANSITION STATE ANALOG, HYDROLYTIC, IMMUNE SYSTEM 
4hg4:P     (GLU1) to   (SER112)  CRYSTAL STRUCTURE OF FAB 2G1 IN COMPLEX WITH A H2N2 INFLUENZA VIRUS HEMAGGLUTININ  |   VIRAL PROTEIN/IMMUNE SYSTEM, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX 
4hix:H     (VAL2) to   (VAL111)  CRYSTAL STRUCTURE OF A HUMANISED 3D6 FAB BOUND TO AMYLOID BETA PEPTIDE  |   IMMUNOGLOBULIN, IMMUNOTHERAPY CANDIDATE, AMYLOID BETA PEPTIDE, PROTEIN FIBRIL-IMMUNE SYSTEM COMPLEX 
3eyo:B     (VAL2) to   (VAL123)  CRYSTAL STRUCTURE OF ANTI-HUMAN CYTOMEGALOVIRUS ANTIBODY 8F9  |   HUMAN CYTOMEGALOVIRUS, ANTIBODY, IMMUNOGLOBULIN DOMAIN, IMMUNE SYSTEM 
3eyo:D     (ARG3) to   (SER124)  CRYSTAL STRUCTURE OF ANTI-HUMAN CYTOMEGALOVIRUS ANTIBODY 8F9  |   HUMAN CYTOMEGALOVIRUS, ANTIBODY, IMMUNOGLOBULIN DOMAIN, IMMUNE SYSTEM 
2bjm:L     (ALA2) to   (GLU110)  SPE7:ANTHRONE COMPLEX  |   IMMUNE SYSTEM, ENCOUNTER COMPLEX 
4x7c:D     (ASP1) to   (SER119)  CRYSTAL STRUCTURE OF SAGA-2006 GII.4 P DOMAIN IN COMPLEX WITH NANO-85  |   NANOBODY, VHH DOMAIN, NOROVIRUS, PROTRUDING DOMAIN, VIRAL PROTEIN 
3fo9:B     (VAL2) to   (SER112)  CRYSTAL STRUCTURE OF ALDOLASE ANTIBODY 33F12 FAB' IN COMPLEX WITH HAPTEN 1,3-DIKETONE  |   ALDOLASE ANTIBODY, ENAMINE INTERMEDIATE, AMINE CATALYSIS, IMMUNE SYSTEM 
1p4b:L     (ALA2) to   (LEU148)  THREE-DIMENSIONAL STRUCTURE OF A SINGLE CHAIN FV FRAGMENT COMPLEXED WITH THE PEPTIDE GCN4(7P-14P).  |   FV ANTIBODY, ANTIGEN PEPTIDE BINDER, SCFV, PICOMOLAR BINDER, IMMUNE SYSTEM 
2dqi:H     (ASP1) to   (SER112)  CRYSTAL STRUCTURE OF HYHEL-10 FV MUTANT (LY50A) COMPLEXED WITH HEN EGG LYSOZYME  |   ANTIGEN-ANTIBODY COMPLEX, MUTANT, IMMUNE SYSTEM/HYDROLASE COMPLEX 
1qrn:E     (GLY3) to   (GLU117)  CRYSTAL STRUCTURE OF HUMAN A6 TCR COMPLEXED WITH HLA-A2 BOUND TO ALTERED HTLV-1 TAX PEPTIDE P6A  |   HUMAN TCR/PEPTIDE/MHC COMPLEX, HLA-A2, HTLV-1, TAX, TCR, T CELL RECEPTOR, IMMUNE SYSTEM 
3hg1:E     (THR3) to   (GLU115)  GERMLINE-GOVERNED RECOGNITION OF A CANCER EPITOPE BY AN IMMUNODOMINANT HUMAN T CELL RECEPTOR  |   T-CELL RECEPTOR, CDR3, PHAGE DISPLAY, MELAN-1, MART-1, IMMUNE SYSTEM, DISULFIDE BOND, TRANSMEMBRANE, DISEASE MUTATION, GLYCATION, GLYCOPROTEIN, IMMUNE RESPONSE, IMMUNOGLOBULIN DOMAIN, MHC I, PYRROLIDONE CARBOXYLIC ACID, SECRETED 
2eks:B     (GLN1) to   (SER113)  CRYSTAL STRUCTURE OF HUMANIZED HYHEL-10 FV-HEN LYSOZYME COMPLEX  |   IMMUNE SYSTEM, HYDROLASE, IMMUNE SYSTEM/HYDROLASE COMPLEX 
1rup:H     (ARG1) to   (SER112)  CRYSTAL STRUCTURE (G) OF NATIVE CATIONIC CYCLIZATION ANTIBODY 4C6 FAB AT PH 8.5 WITH A DATA SET COLLECTED AT APS BEAMLINE 19-ID  |   IMMUNOGLOBULIN, CATALYTIC ANTIBODY, WATER OXIDATION, AMINO ACID MODIFICATION, IMMUNE SYSTEM 
1h0d:B     (VAL2) to   (VAL111)  CRYSTAL STRUCTURE OF HUMAN ANGIOGENIN IN COMPLEX WITH FAB FRAGMENT OF ITS MONOCLONAL ANTIBODY MAB 26-2F  |   IMMUNE SYSTEM/HYDROLASE, COMPLEX (ANTIBODY/HYDROLASE), RIBONUCLEASE, ANTIBODY 
2w9e:H     (GLU1) to   (SER115)  STRUCTURE OF ICSM 18 (ANTI-PRP THERAPEUTIC ANTIBODY) FAB FRAGMENT COMPLEXED WITH HUMAN PRP FRAGMENT 119-231  |   FAB, PRP, PRION, MEMBRANE, GPI-ANCHOR, LIPOPROTEIN, GOLGI APPARATUS, DISEASE MUTATION, IMMUNE SYSTEM, GLYCOPROTEIN, CELL MEMBRANE 
5a2i:H     (VAL2) to   (VAL111)  CRYSTAL STRUCTURE OF SCFV-SM3 IN COMPLEX WITH APD-SGALNAC-RP  |   IMMUNE SYSTEM, GLYCOPEPTIDES, ANTIBODIES, MOLECULAR RECOGNITION, CONFORMATION ANALYSIS, FUSION PROTEIN 
2igf:H     (VAL2) to   (SER112)  CRYSTAL STRUCTURES OF AN ANTIBODY TO A PEPTIDE AND ITS COMPLEX WITH PEPTIDE ANTIGEN AT 2.8 ANGSTROMS  |   IMMUNOGLOBULIN 
1xgt:B     (GLU1) to   (VAL111)  STRUCTURE FOR ANTIBODY HYHEL-63 Y33L MUTANT COMPLEXED WITH HEN EGG LYSOZYME  |   HYHEL-63, 2.1A CRYSTAL STRUCTURE, Y33L MUTANT, IMMUNE SYSTEM 
1yef:H     (MET2) to   (SER112)  STRUCTURE OF IGG2A FAB FRAGMENT (D2.3) COMPLEXED WITH SUBSTRATE ANALOGUE  |   CATALYTIC ANTIBODY 
1yeh:H     (MET2) to   (SER112)  STRUCTURE OF IGG2A FAB FRAGMENT  |   CATALYTIC ANTIBODY, IMMUNOGLOBULIN C REGION 
3lex:H     (ASP1) to   (SER111)  2F5 EPITOPE SCAFFOLD ELICITED ANTI-HIV-1 MONOCLONAL ANTIBODY 11F10 IN COMPLEX WITH HIV-1 GP41  |   HIV-1, GP-41, MONOCLONAL ANTIBODY, 2F5, SCAFFOLD, EPITOPE, TRANSPLANT, GRAFT, RE-ELCITATION, ENVELOPE PROTEIN, IMMUNE SYSTEM, VACCINE DESIGN 
3lex:A     (ASP1) to   (SER111)  2F5 EPITOPE SCAFFOLD ELICITED ANTI-HIV-1 MONOCLONAL ANTIBODY 11F10 IN COMPLEX WITH HIV-1 GP41  |   HIV-1, GP-41, MONOCLONAL ANTIBODY, 2F5, SCAFFOLD, EPITOPE, TRANSPLANT, GRAFT, RE-ELCITATION, ENVELOPE PROTEIN, IMMUNE SYSTEM, VACCINE DESIGN 
3d39:E     (GLY3) to   (GLU117)  THE COMPLEX BETWEEN TCR A6 AND HUMAN CLASS I MHC HLA-A2 WITH THE MODIFIED HTLV-1 TAX (Y5(4-FLUOROPHENYLALANINE)) PEPTIDE  |   HTLV-1 TAX PEPTIDE, 4-FLUOROPHENYLALANINE, MHC CLASS I, HLA-A2, T- CELL RECEPTOR A6, GLYCOPROTEIN, HOST-VIRUS INTERACTION, IMMUNE RESPONSE, MEMBRANE, MHC I, PHOSPHOPROTEIN, TRANSMEMBRANE, DISEASE MUTATION, GLYCATION, IMMUNOGLOBULIN DOMAIN, PYRROLIDONE CARBOXYLIC ACID, SECRETED, IMMUNE SYSTEM